- More immunotherapy regimens 'desperately needed' for salvage treatment of advanced NSCLC – Healio
- Immunotherapy reduced risk of skin cancer development by almost 75 percent – Harvard Gazette
- Northside Hospital Cancer Institute expands its immunotherapy treatment for patients with certain cancers – MDJOnline.com
- Roche's Tecentriq secures another immunotherapy first – BioPharma Dive
- Study points to new strategy for boosting immunotherapy effectiveness in advanced colorectal cancer – Medical Xpress
- New U.K. Partnership Aims To Improve Access Immunotherapy For Cancer Patients – Forbes
- Northside Hospital to expand biological therapy for certain cancers – Atlanta Journal Constitution